SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-075214
Filing Date
2023-03-21
Accepted
2023-03-21 06:48:50
Documents
2
Period of Report
2023-03-21

Document Format Files

Seq Description Document Type Size
1 6-K d485563d6k.htm 6-K 8335
2 EX-99.1 d485563dex991.htm EX-99.1 18731
  Complete submission text file 0001193125-23-075214.txt   28089
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38452 | Film No.: 23747803
SIC: 2834 Pharmaceutical Preparations